SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-014023
Filing Date
2018-11-09
Accepted
2018-11-08 17:38:47
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20180930-10q.htm 10-Q 950104
2 EXHIBIT 4.2 ex-42x20180930.htm EX-4.2 1368
3 EXHIBIT 10.1 ex-101x20180930.htm EX-10.1 1793419
4 EXHIBIT 31.1 ex-311x20180930.htm EX-31.1 12032
5 EXHIBIT 31.2 ex-312x20180930.htm EX-31.2 12060
6 EXHIBIT 32.1 ex-321x20180930.htm EX-32.1 11818
13 ex42image1.jpg GRAPHIC 218984
14 ex42image2.jpg GRAPHIC 550073
  Complete submission text file 0001628280-18-014023.txt   7101648

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgls-20180930.xml EX-101.INS 812831
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20180930.xsd EX-101.SCH 30665
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20180930_cal.xml EX-101.CAL 51413
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20180930_def.xml EX-101.DEF 160940
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20180930_lab.xml EX-101.LAB 447010
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20180930_pre.xml EX-101.PRE 249488
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 181170824
SIC: 2834 Pharmaceutical Preparations